Chemistry analyzer A

Glucose · lot comparison · Chemistry analyzer A

Glucose (mg/dL) · Reagent lot comparison

Criteria met

2 of 2 questions judged · Specimens and Lot plan met

Instrument
Chemistry analyzer A (CA-41027)
Previous lot
GLU-R2609
New lot
GLU-R2610
Study date
Oct 8, 2026

Table 1. Acceptance criteria

QuestionLimitFindingResult
Specimens95% within ±6 mg/dL or ±8% of the previous lot, whichever is greater20 of 20 withinMet
Lot plan20 matched pairs, each level in its planned range20 pairsMet
−40−2002040Level 12–750New − previous (mg/dL)Planned levelSpecimen LC-01: difference +1.0 mg/dL, allowed ±6.0 mg/dL, within limitSpecimen LC-02: difference −1.0 mg/dL, allowed ±6.0 mg/dL, within limitSpecimen LC-03: difference +1.0 mg/dL, allowed ±6.0 mg/dL, within limitSpecimen LC-04: difference +1.0 mg/dL, allowed ±6.0 mg/dL, within limitSpecimen LC-05: difference −1.0 mg/dL, allowed ±6.7 mg/dL, within limitSpecimen LC-06: difference +2.0 mg/dL, allowed ±7.7 mg/dL, within limitSpecimen LC-07: difference −1.0 mg/dL, allowed ±8.6 mg/dL, within limitSpecimen LC-08: difference +2.0 mg/dL, allowed ±9.4 mg/dL, within limitSpecimen LC-09: difference +2.0 mg/dL, allowed ±10.1 mg/dL, within limitSpecimen LC-10: difference −2.0 mg/dL, allowed ±11.1 mg/dL, within limitSpecimen LC-11: difference +3.0 mg/dL, allowed ±12.2 mg/dL, within limitSpecimen LC-12: difference −2.0 mg/dL, allowed ±13.4 mg/dL, within limitSpecimen LC-13: difference +3.0 mg/dL, allowed ±14.8 mg/dL, within limitSpecimen LC-14: difference −3.0 mg/dL, allowed ±16.3 mg/dL, within limitSpecimen LC-16: difference −4.0 mg/dL, allowed ±21.0 mg/dL, within limitSpecimen LC-17: difference +5.0 mg/dL, allowed ±23.8 mg/dL, within limitSpecimen LC-18: difference −5.0 mg/dL, allowed ±27.4 mg/dL, within limitSpecimen LC-19: difference +7.0 mg/dL, allowed ±32.1 mg/dL, within limitSpecimen LC-20: difference −8.0 mg/dL, allowed ±39.0 mg/dL, within limitSpecimen LC-21: difference +9.0 mg/dL, allowed ±49.0 mg/dL, within limitLevel 1: mean difference +0.5 mg/dL±6 or 8%
Figure 1. Each specimen’s difference by planned level, in order of concentration; dash-dot: its allowed difference; open diamonds: level mean difference.

Mean difference (new − previous) over 20 pairs +0.5 mg/dL (95% CI −1.4 to 2.3); SD of the differences 4.03 mg/dL.

Study details

Matrix
Serum
Method
Hexokinase
Calibrator lot
GLU-C2609
Data
40 included · 2 excluded
Alex Rivera, MLS(ASCP)
alex.rivera@example.test
Signed off by
Oct 23, 2026, 13:25 UTCDate

A Data listing

Source: CHEM-A_results_20261008.csv. Patient specimens. 42 rows.

Study rowSpecimenLotOriginal (mg/dL)Current (mg/dL)IncludedSource rowNote
1LC-01GLU-R26092828Yes2
2LC-02GLU-R26094545Yes4
3LC-03GLU-R26096161Yes6
4LC-04GLU-R26097272Yes8
5LC-05GLU-R26098484Yes10
6LC-06GLU-R26099696Yes12
7LC-07GLU-R2609108108Yes14
8LC-08GLU-R2609117117Yes16
9LC-09GLU-R2609126126Yes18
10LC-10GLU-R2609139139Yes20
11LC-11GLU-R2609152152Yes22
12LC-12GLU-R2609168168Yes24
13LC-13GLU-R2609185185Yes26
14LC-14GLU-R2609204204Yes28
15LC-15GLU-R2609231231No30Excluded: Clot flagged by analyzer
16LC-16GLU-R2609263263Yes32
17LC-17GLU-R2609298298Yes34
18LC-18GLU-R2609342342Yes36
19LC-19GLU-R2609401401Yes38
20LC-20GLU-R2609487487Yes40
21LC-21GLU-R2609612612Yes42
22LC-01GLU-R26102929Yes44
23LC-02GLU-R26104444Yes45
24LC-03GLU-R26106262Yes46
25LC-04GLU-R26107373Yes47
26LC-05GLU-R26108383Yes48
27LC-06GLU-R26109898Yes49
28LC-07GLU-R26101O7107Yes50
29LC-08GLU-R2610119119Yes51
30LC-09GLU-R2610128128Yes52
31LC-10GLU-R2610137137Yes53
32LC-11GLU-R2610155155Yes54
33LC-12GLU-R2610166166Yes55
34LC-13GLU-R2610188188Yes56
35LC-14GLU-R2610201201Yes57
36LC-15GLU-R2610198198No58Excluded: Clot flagged by analyzer
37LC-16GLU-R2610259259Yes59
38LC-17GLU-R2610303303Yes60
39LC-18GLU-R2610337337Yes61
40LC-19GLU-R2610408408Yes62
41LC-20GLU-R2610479479Yes63
42LC-21GLU-R2610621621Yes64

1 Results

1.1 Specimen results

02004006000200400600New lot GLU-R2610 (mg/dL)Previous lot GLU-R2609 (mg/dL)Specimen LC-01: previous 28.0, new 29.0 mg/dL, within limitSpecimen LC-02: previous 45.0, new 44.0 mg/dL, within limitSpecimen LC-03: previous 61.0, new 62.0 mg/dL, within limitSpecimen LC-04: previous 72.0, new 73.0 mg/dL, within limitSpecimen LC-05: previous 84.0, new 83.0 mg/dL, within limitSpecimen LC-06: previous 96.0, new 98.0 mg/dL, within limitSpecimen LC-07: previous 108.0, new 107.0 mg/dL, within limitSpecimen LC-08: previous 117.0, new 119.0 mg/dL, within limitSpecimen LC-09: previous 126.0, new 128.0 mg/dL, within limitSpecimen LC-10: previous 139.0, new 137.0 mg/dL, within limitSpecimen LC-11: previous 152.0, new 155.0 mg/dL, within limitSpecimen LC-12: previous 168.0, new 166.0 mg/dL, within limitSpecimen LC-13: previous 185.0, new 188.0 mg/dL, within limitSpecimen LC-14: previous 204.0, new 201.0 mg/dL, within limitSpecimen LC-16: previous 263.0, new 259.0 mg/dL, within limitSpecimen LC-17: previous 298.0, new 303.0 mg/dL, within limitSpecimen LC-18: previous 342.0, new 337.0 mg/dL, within limitSpecimen LC-19: previous 401.0, new 408.0 mg/dL, within limitSpecimen LC-20: previous 487.0, new 479.0 mg/dL, within limitSpecimen LC-21: previous 612.0, new 621.0 mg/dL, within limit
Figure 2. New lot against previous lot; dotted line: equal results.
−40−20020400200400600New − previous (mg/dL)Previous lot GLU-R2609 (mg/dL)Specimen LC-01: difference +1.0 mg/dL, allowed ±6.0 mg/dL, within limitSpecimen LC-02: difference −1.0 mg/dL, allowed ±6.0 mg/dL, within limitSpecimen LC-03: difference +1.0 mg/dL, allowed ±6.0 mg/dL, within limitSpecimen LC-04: difference +1.0 mg/dL, allowed ±6.0 mg/dL, within limitSpecimen LC-05: difference −1.0 mg/dL, allowed ±6.7 mg/dL, within limitSpecimen LC-06: difference +2.0 mg/dL, allowed ±7.7 mg/dL, within limitSpecimen LC-07: difference −1.0 mg/dL, allowed ±8.6 mg/dL, within limitSpecimen LC-08: difference +2.0 mg/dL, allowed ±9.4 mg/dL, within limitSpecimen LC-09: difference +2.0 mg/dL, allowed ±10.1 mg/dL, within limitSpecimen LC-10: difference −2.0 mg/dL, allowed ±11.1 mg/dL, within limitSpecimen LC-11: difference +3.0 mg/dL, allowed ±12.2 mg/dL, within limitSpecimen LC-12: difference −2.0 mg/dL, allowed ±13.4 mg/dL, within limitSpecimen LC-13: difference +3.0 mg/dL, allowed ±14.8 mg/dL, within limitSpecimen LC-14: difference −3.0 mg/dL, allowed ±16.3 mg/dL, within limitSpecimen LC-16: difference −4.0 mg/dL, allowed ±21.0 mg/dL, within limitSpecimen LC-17: difference +5.0 mg/dL, allowed ±23.8 mg/dL, within limitSpecimen LC-18: difference −5.0 mg/dL, allowed ±27.4 mg/dL, within limitSpecimen LC-19: difference +7.0 mg/dL, allowed ±32.1 mg/dL, within limitSpecimen LC-20: difference −8.0 mg/dL, allowed ±39.0 mg/dL, within limitSpecimen LC-21: difference +9.0 mg/dL, allowed ±49.0 mg/dL, within limit±6 or 8%
Figure 3. Each specimen’s difference with its allowed range.
Table 2. Specimen results (mg/dL)
SpecimenPrevious lot GLU-R2609New lot GLU-R2610DifferenceAllowedResult
LC-012829+1.0±6.0
LC-024544−1.0±6.0
LC-036162+1.0±6.0
LC-047273+1.0±6.0
LC-058483−1.0±6.7
LC-069698+2.0±7.7
LC-07108107−1.0±8.6
LC-08117119+2.0±9.4
LC-09126128+2.0±10.1
LC-10139137−2.0±11.1
LC-11152155+3.0±12.2
LC-12168166−2.0±13.4
LC-13185188+3.0±14.8
LC-14204201−3.0±16.3
LC-16263259−4.0±21.0
LC-17298303+5.0±23.8
LC-18342337−5.0±27.4
LC-19401408+7.0±32.1
LC-20487479−8.0±39.0
LC-21612621+9.0±49.0

Difference = new − previous.

1.2 Plan coverage

Table 3. Plan coverage

LevelPrevious-lot results (mg/dL)Inside the planned range
128–61220 of 20

1.3 Reportable-range coverage · Coverage describes the span of observed concentrations inside the claimed interval. It does not make an acceptance decision.

Table 4. Observed and claimed ranges

LevelAxisClaimed (mg/dL)Observed (mg/dL)Coverage (%)
*Previous lot GLU-R26092.0–750.028.0–612.078.1

Supporting diagnostics

S.1 Difference detail

Table 5. Differences by level

LevelPercentage mean (%)Percentage 95% CI (%)
1+0.4−0.5 to 1.2

Percentage difference = 100 × (new − previous) / mean of the two lot results. For information; the lot decision uses the limits on page 1.

B Methods

B.1 Additional study details

CAP COM.30450 · 9 December 2025New reagent lots and shipments, including shipments of the same lot. Supporting sections: Study details; Decision page; Data listing. Associated laboratory evidence: Material suitability and lot or shipment acceptance records.
CAP COM.40475 · 9 December 2025Approval of nonwaived test validation or verification before clinical use. Supporting sections: Decision page; Sign-off. Associated laboratory evidence: Director or qualified designee signed written assessment and approval tied to each test and instrument.
CAP GEN.20377 · 9 December 2025Laboratory record retention. Supporting sections: Evidence archive. Associated laboratory evidence: Keep method validation and verification records for the life of the test plus two years, or longer when applicable retention rules require it.
CAP GEN.20450 · 9 December 2025Corrections to laboratory records. Supporting sections: Data listing; Audit trail. Associated laboratory evidence: Retained original values and traceable corrections.

B.2 Statistical methods applied

  1. Each specimen’s replicates are averaged on each lot. Difference = new − previous, in the study unit. A positive difference means the new lot reads higher. Percentage difference = 100 × (new − previous) / mean of the two lot results. It needs a ratio scale, results of 0 or more and a mean above the near-zero floor.
  2. A specimen measured on one lot only has no difference but counts in the acceptance total.
  3. The mean shift has a 95% Student t CI.
  4. The lot passes when at least 95% of patient specimens (rounded up to a whole specimen, so every one of fewer than 20) meet their allowable difference, there are at least 2 specimens and the lot plan is complete. A percentage limit is ± percentage × previous-lot result / 100. It needs a ratio scale and a positive previous-lot result. A combined absolute-and-percentage limit uses the larger allowance, or both must be met, as the limit says. Concentration-dependent limits take each specimen’s segment from its previous-lot result.
  5. An optional mean-difference limit judges the mean of the matched differences, in the study unit or as the mean percentage difference, against the entered bounds on the exact entered values; it needs at least 2 matched pairs and fails the lot when the mean is beyond it.
  6. A specimen allowance below 1.96 × the SD of a matched difference from imprecision alone (the pooled within-specimen SD of a level’s replicated specimens on both lots, times √(1/k₁ + 1/k₂) for the replicates each pair averages) is cautioned with the share of specimens imprecision alone would put outside it. The caution changes no decision.
  7. The lot plan sets the pairs needed at each concentration level. Without one, each level in the data needs the calculation minimum of 2 pairs, and rows without a level form one group. A level is complete when enough pairs fall inside its planned range, if one is set. Missing pairs or unplanned levels make the decision inconclusive.
  8. Specimen IDs starting with QC are QC material. They are summarized by material and lot and kept out of acceptance. Pass/fail uses the exact entered values.
  9. Reportable-range coverage is the width of the overlap between the observed reference-axis range and the claimed reportable range, divided by the claimed range width, times 100. It describes the tested span; accuracy and verification of the reportable range are separate questions. Replicate results are averaged by specimen before determining the observed range.

B.3 Decision rules and display precision

  1. Each acceptance criterion compares the unrounded estimate with its limit. Limits include their end values unless marked exclusive. A criterion with a missing estimate, too little data or a failed fit is inconclusive and does not count as met.
  2. Entered results, claims, targets and acceptance limits are shown as entered. Calculated concentrations, SDs and fitted parameters are shown to 1 decimal place. Very small or large values use exponent notation at the same precision. An SD or limit that would round to zero keeps two significant digits.

C Audit trail

Data version3
Criteria version1
Methodreagent or calibrator lot comparison (method ID LMS-LOT-1.20)
Criteria evaluationacceptance criteria evaluation (method ID LMS-CRITERIA-1.1)
Import CHEM-A_results_20261008.csvSHA-256 37ff6c03551d594011fc1b7def7c4e0a9715c89ed9e4e3b3c0d90813157234ff
Report software0.1.0 · templates 2a6731123b96